GCJBP to submit clinical data of Laennec placenta injection

Published: 2009-04-01 06:58:00

Updated: 2009-04-01 06:58:00

GCJBP, a local importer of Laennec placenta injection from Japan Bio Products (JBP), says it is scheduled to submit clinical data of Laennec placenta injection to the Korea Food and Drug Administration at the end of this year, clarifying that the results of placenta injection, which was recently ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK